-
Mashup Score: 0
After the recent approval of 177Lu in PSMA+/mCPRCP prior to chemotherapy, Steven Finkelstein, MD, DABR, FACRO, highlights the importance of this milestone.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9Can less differentiation drive CARs to success? - 6 hour(s) ago
In this issue of Blood, Caballero et al1 present the results of a small phase 1 clinical trial of second-generation CD30-directed chimeric antigen receptor
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8Acute Myeloid Leukemia - VJHemOnc - 12 hour(s) ago
Explore the latest Acute Myeloid Leukemia updates and expert interviews on The AML Channel from VJHemOnc
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Meeting News Articles | Blood Cancers Today - 1 day(s) ago
Read the latest content on meeting news curated for hematologic oncologists.
Source: www.bloodcancerstoday.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Atezolizumab Provides No Benefit in Head and Neck Cancer - 3 day(s) ago
Atezolizumab after multi-modal definitive treatment did not improve outcomes in patients with locally advanced head and neck cancer.
Source: www.cancertherapyadvisor.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
View the guidelines and practice parameters are available for public comment.
Source: www.astro.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Suresh Senan, MRCP, FRCR, PhD, Amsterdam University Medical Centers, Amsterdam, Netherlands, discusses findings from the ADRIATIC study (NCT03703297) of durvalumab consolidation therapy in patients with limited-stage small cell lung cancer (LS-SCLC). Results suggest durvalumab consolidation therapy reduced extrathoracic metastases and prolonged time to progression or death compared to placebo. This interview took place at the European Lung Cancer Congress (ELCC) 2025 in Paris, France. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjoncology.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Cracking the Code, Understanding Number and Acuity of Diagnosis in Medical Decision Making - SGO on the GO - 3 day(s) ago
Allison Barrie, MD, and Stephen Bush, MD, from the SGO Coding and Reimbursement Subcommittee share their expertise in E/M coding to unlock the secrets of using the number and complexity of diagnoses to support your billing of inpatient and outpatient visits. One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Chair of the SGO Coding and Reimbursement Subcommittee.
Source: www.buzzsprout.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
PURPOSEThe purpose of our study was to (1) use a large language model (LLM) to identify goals-of-care (GOC) conversations in a large volume of notes, and (2) explore the potential of LLMs for a novel summarization task.METHODSWe included patients …
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0VJOncology – The video journal of oncology - 3 day(s) ago
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology
Source: www.vjoncology.comCategories: General Medicine News, Onc News and JournalsTweet
On April 3, 2025, Steven Finkelstein, MD, DABR, FACRO, and his team were the first in the US to administer the recently approved lutetium Lu 177 to a patient with metastatic castration-resistant prostate cancer. #pcsm https://t.co/LoNSC9eCWj